NASDAQ OMX

Karolinska Development's portfolio company Modus Therapeutics announces publication of Phase I/II data demonstrating anti-adhesive properties of sevuparin

Dela

STOCKHOLM, December 20, 2017. Karolinska Development announced today that data from a Phase I/II study of sevuparin in malaria patients was published in an on-line version of the renowned scientific journal PLOS ONE. The paper demonstrates the anti-adhesive properties of sevuparin in patients with malaria. Karolinska Development's portfolio company Modus Therapeutics is currently conducting a Phase II study with sevuparin in patients with sickle cell disease, with an estimated read out in 2018.

Sevuparin is a drug candidate currently being developed for the treatment of sickle cell disease (SCD) and the paper published in PLOS ONE provides the first clinical evidence of anti-adhesive action of sevuparin. SCD is caused by a mutation in the hemoglobin gene which leads to the red blood cells becoming sickled in shape and sticky, attaching to other blood cells and to blood vessels walls. This leads to reduced blood flow and impaired transport of oxygen to vital organs.

The Phase I/II trial was a randomized, open label, active control, parallel assignment clinical study in which sevuparin was administered via short intravenous infusions to patients with uncomplicated malaria who were also receiving atovaquone/proguanil treatment.

Amongst the key findings of the study, which were highlighted in the PLOS ONE publication, were:

  • Sevuparin was safe and well tolerated in malaria patients
  • Sevuparin, due to its anti-adhesive properties, was able to open up previously clogged blood vessels
  • Sevuparin rapidly inhibited the growth of the Plasmodium falciparum, the parasite that causes malaria

This is the first time that these results have been achieved in humans.

The paper titled, "Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria," can be found here:
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0188754

For further information, please contact :

Viktor Drvota, CEO, Karolinska Development AB
Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com

TO THE EDITORS

About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The Company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patients' lives while providing an attractive return on investment to shareholders.

Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.

Karolinska Development has established a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.

The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.

For more information, please visit www.karolinskadevelopment.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Merus to Report Full Year 2017 Financial Results and Corporate Developments on April 26, 201819.4.2018 13:00Pressmeddelande

Conference call scheduled for Thursday, April 26, 2018, at 8:30 a.m. ET UTRECHT, The Netherlands, April 19, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the Company will report full year 2017 financial results on Thursday, April 26, 2018. Merus' management team will host a conference call and audio webcast at 8:30 a.m. ET on Thursday, April 26, 2018, to discuss the financial results and recent clinical and corporate developments. To participate in the call, please dial (877) 260-1463 (U.S.) or (706) 643-5907 (international) and reference conference ID 6184636. A live webcast will be available on the Investors page of the Company's website, http://www.merus.nl. An archived webcast replay will be available for 90 days. About Merus N.V. Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeut

SEMAFO: Construction of Boungou Mine 91% Complete19.4.2018 13:00Pressmeddelande

Commissioning Advancing to Plan MONTREAL, April 19, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) announced that construction of the Boungou Mine in Burkina Faso is 91% complete, and commissioning activities are advancing well with 10% already completed at the end of March. Since launch of commissioning at the end of February, the crushing circuit equipment and water services have been tested and commissioned. The reclaim and grinding circuits, reagent and oxygen plants are also undergoing testing. Wet commissioning began at the end of March with the Corporation pumping water from the water storage facility to the raw water tanks for the processing plant. We are still in line to achieve our first gold pour early in the third quarter of 2018. As at March 31, 2018, the following milestones had been reached: Development on budget with US$194 million of the US$231 million capital expenditure incurred Construction of the mine 91% complete Completion of 98% of structural steel and

Standard Lithium Completes Successful Gravity Geophysical Survey at Cadiz Dry Lake, California Lithium Project19.4.2018 11:30Pressmeddelande

VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLL) (FRA:S5L) is pleased to announce that Hasbrouck Geophysics Inc. has successfully completed a large-scale gravity geophysical survey at the Company's Cadiz Dry Lake Project, in the Mojave area of California. The Cadiz Dry Lake Property is located approximately 20 km southeast of the Company's Bristol Dry Lake Property and is currently permitted for brine extraction and processing activities. The work has defined an infilled basin with a maximum depth of just over 700 m beneath the Project area. Dr. Andy Robinson, COO and President of Standard Lithium commented: "The results from this high quality geophysical survey are very encouraging. This work has defined a closed basin with infill deposits that are known to host lithium brines, based on preliminary sampling of extraction wells operated by the permitted producer. Standard Lithium's excellent relations

ConnectWise Launches Unite, Its Cloud Monitoring, Management and Billing Solution19.4.2018 10:03Pressmeddelande

IT Nation Europe keynote also reveals plans for an advanced security dashboard and growing the company's international footprint LONDON, April 19, 2018 (GLOBE NEWSWIRE) -- ConnectWise CEO Arnie Bellini told an audience of more than 350 at the company's annual IT Nation Europe conference in London that ConnectWise Unite is now available to technology teams across the globe. Unite is a cloud management solution that gives technology teams the ability to manage, monitor and bill a broad range of cloud-based solutions through a single pane of glass and in their own currency. "Technology teams typically take advantage of a broad range of cloud solutions to meet their customers' unique needs. What we've done with ConnectWise Unite is give our partners the ability to access these disparate solutions from a single pane of glass and greatly simplify the complexity that comes from dealing with the growing number of solutions they use," Bellini said. He explained that connecting the ecosystem sea

D4t4 Solutions Announces Latest Celebrus Release19.4.2018 10:00Pressmeddelande

Celebrus Advances Customer Data Platform Leadership Further with New Product Features Latest update consolidates Celebrus as enterprise CDP of choice for banking and insurance sectors Integration with Adobe Experience Cloud augments leading digital marketing platform with streaming customer data New Audience Segmentation feature enables advanced targeting of individuals even when they have left a site or app Latest connector supports creation of Custom Audiences in Google and Facebook Hadoop capabilities extended with enhanced support for Hive open-source data warehouse SUNBURY-ON-THAMES, United Kingdom, April 19, 2018 (GLOBE NEWSWIRE) -- D4t4 Solutions Plc has announced general availability for the latest release of its leading Celebrus Customer Data Platform (CDP). Continuing its commitment to creating the industry's most advanced unified system for customer data, Version 8 Update 19 delivers a host of new features that broaden the appeal of Celebrus to enterprises focused on deepeni

Leading European Media Company De Persgroep Selects Aria Systems for Digital Transformation19.4.2018 09:08Pressmeddelande

Aria's cloud billing and monetization platform will manage millions of subscriptions across dozens of media properties SAN FRANCISCO and ASSE, Belgium, April 19, 2018 (GLOBE NEWSWIRE) -- Aria Systems, the leader in helping enterprises grow subscription- and usage-based revenue, today announced that De Persgroep, the leading news media publisher in the Netherlands, Belgium and Denmark, is deploying Aria's platform to enable their digital growth strategy. With Aria the company will accelerate time to market for new products, increase subscriber growth and retention, and improve the overall customer experience. Among the publications included in this digital strategy are 18 newspapers and periodicals across the portfolios of De Persgroep Publishing, De Persgroep Nederland, and Berlingske Media. De Persgroep selected Aria's cloud-based billing and monetization platform to support the subscription management processes for all news media and magazine subscriptions. The company can now manage

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum